Why is rectal cannabinoid delivery being studied as an alternative to traditional oral cannabis?
hat makes THC-HS different from conventional THC or cannabis oils such as RSO?
Could bypassing much of first-pass metabolism change how cannabinoids are absorbed and sustained in the body?
Why has THC-HS attracted attention in pharmacokinetic research involving rectal administration?
Could more predictable cannabinoid exposure eventually matter when studying cancer-associated pain, appetite, sleep, nausea and overall comfort?
What does existing cannabinoid research actually tell us about THC, tumor-cell signaling and apoptosis?
How is ENDURA being developed as a specialized THC-HS suppository platform for advanced treatment for people living with cancer?
Why ENDURA represents a worthwhile next step for controlled research into cannabinoid delivery, tolerability and cancer-associated symptom support and relief?
ENDURA — Where Cannabinoid Science Meets Advanced Delivery
Our free guide explains ENDURA and the emerging research in plain language, including what scientists know, and what remains investigational. “Research without the hype. No complicated jargon. No purchase required.”
Educational information designed to help you better understand emerging phytocannabinoids and cancer research.